Results 71 to 80 of about 10,055 (118)

应用生物信息学分析鉴定TCGA数据库中胃癌预后不良的重要基因

Zhongguo shiyan zhenduanxue
研究发现胃癌是世界上癌症死亡的第二大原因，是我国常见的恶性肿瘤，同样胃癌是世界上发病率和死亡率较高的恶性消化道肿瘤，做到早期诊断早期手术是决定患者预后的重要因素，且胃癌患者的预后严重影响着患者的生存质量，因此寻找新的预后基因对胃癌治疗恢复有重要的意义，胃癌的发生与基因调控、环境因素、饮食习惯等都有很密切关系，且认为基因调控是发病的主要因素，同时胃癌的预后也与很多基因有密切关系，因进展期、术后复发及耐药的患者而言 ...
吕楠, 潘楠, 马太原, 唐桂艳
doaj  

[Analysis of urine biomarkers in urothelial carcinoma based on untargeted metabolomics]. [PDF]

Se Pu
Liu S, Wang M, Wang W.
europepmc   +1 more source

[Heterogeneity of tumor-associated macrophages and precision targeting strategies in hepatocellular carcinoma]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Huang K, Zhang GQ.
europepmc   +1 more source

白细胞介素-1B -511T/C多态性与不同临床 病理学类型胃癌的关系

Zhongshan Daxue xuebao. Yixue kexue ban, 2009
【目的】 研究中国人白细胞介素(IL)-1B -511T/C多态性与不同临床病理学特征胃癌的遗传易感性的关系及其对胃癌患者预后的影响65377; 【方法】 采用聚合酶链反应-限制性长度片段多态性(PCR-RFLP)对563例胃癌及500例健康对照进行IL-1B -511位点基因分型,分析该多态性与不同临床病理学类型胃癌发病风险关系并对其预后进行生存分析65377;【结果】 IL-1B -511T/C多态性与胃癌遗传易感性相关,携带IL-1B -511T等位基因者发生胃癌的风险较CC基因型增加(OR =
doaj  

[Quercetin inhibits proliferation and migration and promotes apoptosis of gastric cancer cells by promoting phosphorylation-mediated YAP inactivation]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Wang Y, Wang W, Cheng S, Feng Y, Zhang Z, Shi Q, Li Y, Hu Q, Wu M.   +8 more
europepmc   +1 more source

[High expression of MPP6 predicts poor patient prognosis and promotes malignant biological behaviors of hepatocellular carcinoma cells]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Yu H, Shao Y, Cheng Q, Zhou X, Geng H, Yang Y.   +5 more
europepmc   +1 more source

[cGAS-STING agonist cGAMP enhances natural killer cell-mediated cytotoxicity against gastric cancer cells]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Wang Q, Chai Z, Deng Y, Zhang Z, Gong Y, Gao S, Feng P.   +6 more
europepmc   +1 more source

[ERI3 expression is elevated in hepatocellular carcinoma and correlates with poor patient prognosis]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhao X, Wang H, Song Y, Yuan S, Zhang Z, Zhou X, Li S, Li X, Li F.   +8 more
europepmc   +1 more source

[Research progress in liver cancer in 2025]. [PDF]

Zhonghua Gan Zang Bing Za Zhi
Miao TG, Nan YM.
europepmc   +1 more source

[Fertility management in breast cancer patients: current strategies and research advances]. [PDF]

Zhejiang Da Xue Xue Bao Yi Xue Ban
Zhou J, Jin M, Huang H.
europepmc   +1 more source